Search for evidence of a Th2 profile in HIV + patients

International Journal of Dermatology

Volumn 39, Issue 2, 2000, Pages 109-115

  Gutierrez Galhardo, Maria Clara ^a   Perez, Maurício ^b   Gonçalves Morgado, Mariza ^b   Almeida, Sônia ^b   Soares De Azevedo, Lúcia Maria ^b   Georg, Ingerborg ^b   Ferreira, Helen ^b   Nunes Sarno, Euzenir ^b  

^a Funda??o Oswaldo Cruz   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DIDANOSINE; FLUCONAZOLE; GANCICLOVIR; IMMUNOGLOBULIN E; ISONIAZID; LAMIVUDINE; PYRAZINAMIDE; RIFAMPICIN; RITONAVIR; SAQUINAVIR; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYCOSIS; EOSINOPHIL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; KAPOSI SARCOMA; MALE; MAST CELL; PILOT STUDY; SEBORRHEIC DERMATITIS; SKIN ALLERGY; THRUSH; TUBERCULOSIS; XEROSIS;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; EOSINOPHILS; FEMALE; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN E; MALE; MAST CELLS; MIDDLE AGED; SKIN; SKIN DISEASES; TH2 CELLS;

EID: 0034100798     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00858.x     Document Type: Article

References (34)

1. Mathes B, Douglass M. Seborrheic dermatitis in patients with AIDS. J Am Acad Dermatol 1985; 13: 947-951.
2. Duvic M, Johnson TM, Rapini RP, et al. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol 1987; 123: 1622-1632.
3. Rosenthal D, Leboit PE, Klumpp L, et al. Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency infection. Arch Dermatol 1991; 127: 206-209.
4. Liautaud B, Pape JW, DeHovitz JA, et al. Pruritic skin lesions. A common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol 1989; 125: 629-632.
5. Coopman S, Johnson RA, Platt R, et al. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670-1674.
6. Cleiri M, Shearer GM. A Th1 → Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 107-111.
7. Klein AS, Dobmeyer JM, Dobmeyer TS, et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 1997; 11: 1111-1118.
8. Meroni L, Trabattoni D, Balotta C, et al. Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection. AIDS 1996; 10: 23-30.
9. Graziosi C, Pantaleo G, Gant KR, et al. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Sci 1994; 265: 248-251.
10. Romagnani S, Del Prete G, Manetti R, et al. Role of Th1/Th2 cytokines in HIV infection. Immunol Rev 1994; 140: 73-88.
11. Romagnani S. Lymphokine production by human T cells in disease states. Ann Rev Immunol 1994; 12: 227-257.
12. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989; 7: 145-173.
13. Lewis RE, Buchsbaum M, Whitaker D, et al. Intercellular adhesion molecules expression evolving human cutaneous delayed hypersensitivity reaction. J Invest Dermatol 1989; 93: 672-677.
14. Burd PR, Rogers HW, Gordon JR, et al. Interleukin 3-dependent and independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989; 170: 245-257.
15. Frandji P, Oskéritzian C, Cacaraci F, et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC of class II-restricted T cell hybridoma. J Immunol 1993; 151: 6318-6328.
16. Czarnetzki BM, Wüllenweber I. In vitro migratory response of rat peritoneal macrophages and mast cells towards chemotactic factors and growth factors. J Invest Dermatol 1988; 91: 224-227.
17. Smith KJ, Skelton HG, Drabick JJ, et al. Hypereosinophilia secondary to immunodysregulation in patients with HIV-1 disease. Arch Dermatol 1994; 130: 119-121.
18. Caterino-de-Araújo A. HIV-1 infection and eosinophilia. Immunol Today 1994: 498-499.
19. Cohen AJ, Steigbigel RT. Eosinophilia in patients infected with human immunodeficiency virus. J Clin Infect Dis 1996; 174: 615-618.
20. Center of Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41: 1-19.
21. Markey AC, Churchill LJ, MacDonald DM. Human cutaneous mast cells - a study of fixative and staining reactions in normal skin. Br J Dermatol 1989; 120: 625-631.
22. Paiva DD, Morais JC, Pilotto J, et al. Spectrum of morphologic changes of lymph nodes in HIV infection. Mem Inst Oswaldo Cruz 1996; 91: 371-379.
23. Smith KJ, Skelton HG, Yeager J, et al. Histopathologic and immunohistochemical findings associated with inflammatory dermatoses in human immunodeficiency virus type 1 disease and their correlation with Walter reed stage. J Am Acad Dermatol 1993; 28: 174-184.
24. Smith KJ, Skelton HG, Yeager J, et al. Histologic features of foreign body reactions in patients with human immunodeficiency virus type 1. J Am Acad Dermatol 1993; 28: 470-476.
25. Buschness MR, Gregory N, Lim HW, et al. The role of mast cells and eosinophils in eosinophilic pustular folliculitis of acquired immunodeficiency syndrome. J Invest Dermatol 1989; 92: 408 (Abstract).
26. Simonart Th, Parent D, Heene M, et al. Decreased skin reactivity to codeine in patients with the acquired immunodeficiency syndrome. Clin Immunol Immunopathol 1996; 81: 12-15.
27. Bishop PE, McMillan A, Gilmour HM. Immunological study of the rectal mucosa of men with and without immunodeficiency virus infection. Gut 1987; 28: 1619-1624.
28. Wright DN, Nelson RP Jr, Ledford DK, et al. Serum IgE and human immunodeficiency virus (HIV) infection. J Allergy Clin Immunol 1990; 85: 445-452.
29. Israël-Biot D, Labrousse F, Touraini JM, et al. Elevation of IgE in HIV-infected subjects: a marker of poor prognosis. J Allergy Clin Immunol 1992; 89: 68-75.
30. Birx DL, Brundage J, Larson K, et al. The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients. J Acquir Immune Defic Syndr 1993: 1248-1257.
31. 4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis 1995; 172: 79-87.
32. 4 in HIV-positive patients. J Invest Allergol Clin Immunol 1997; 7: 183-185.
33. Skiest D, Keiser P. Clinical significance of eosinophilia in HIV-infected individuals. Am J Med 1997; 102: 449-453.
34. Sanchez-Borges M, Orozco A, Di Biagio E, et al. Eosinophilia in early-stage human immunodeficiency virus infection. J Allergy Clin Immunol 1993; 92: 494-495.